Amicus Therapeutics to Announce Third Quarter 2012 Financial Results on November 5, 2012

[at noodls] – CRANBURY, N.J., Nov. 1, 2012 (GLOBE NEWSWIRE) — Amicus Therapeutics (Nasdaq:FOLD), a biopharmaceutical company at the forefront of developing therapies for rare and orphan diseases, today announced a … more

View todays social media effects on FOLD

View the latest stocks trending across Twitter. Click to view dashboard